ClinicalTrialsFinder
RecruitingNCT06526520

Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer

Sponsor

ART Fertility Clinics LLC

Enrollment

5 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Frozen Embryo Transfer

Summary

To investigate the levels of Relaxin in different types of endometrial preparation for a frozen embryo transfer cycle. Up to now it is unclear, whether ovulation with a functional corpus luteum (CL) will be present in a natural proliferative phase (NPP) endometrial preparation approach.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Exposure to progesterone or HRT medication for people with frozen embryo transfer. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGExposure to progesterone or HRT medication

to add either progesterone only in the NPP protocol or E2 and progesterone in a HRT protocol

Locations(1)

ART Fertiltiy Clinic

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06526520

Related Trials

Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients

NCT062393761 location

Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer

NCT063071841 location